Udayavni Special

Zydus Cadila files investigational new drug application for COVID-19 treatment


PTI, Nov 3, 2020, 11:54 AM IST

New Delhi: Drug firm Zydus Cadila on Tuesday said it has filed the investigational new drug (IND) application for ZYIL1, positioned for management of critically ill COVID-19 patients.

“Following up on its initiatives to fight COVID-19 with diagnostics, vaccines and therapeutics, the company is now focussing on cutting edge research to bring targeted therapies… it has filed the IND application of ZYIL1, a novel oral small molecule,” the company said in a regulatory filing.

Zydus Cadila said ZYIL1 will bridge a critical unmet healthcare need in several inflammatory diseases including the current pandemic of COVID-19 and address complications caused by chronic and uncontrolled inflammation.

The company said it has completed all IND enabling preclinical studies and has filed the IND application to advance this drug candidate towards the clinic.

Zydus Cadila said ZYIL1, has demonstrated promising efficacy in a number of validated pre-clinical models of Inflammatory Bowel Disease (IBD), Multiple Sclerosis (MS), Sepsis, and acute lung injury models of Acute Respiratory Distress Syndrome (ARDS).

Shares of Cadila Healthcare were trading 7.88 percent higher at Rs 442.45 apiece on BSE.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Pakistan fails to nab 19 most wanted LeT terrorists even 12 years after 26/11 attack

Speculation rife in Karnataka as CM convenes meeting of cabinet, MPs

Farmers’ protest: Vigil stepped up in Delhi’s bordering areas, vehicles being checked

Khattar hits out at Amarinder, tells him to stop ‘inciting’ innocent farmers

PM Modi to visit Serum Institute of India in Pune on Saturday

Militant attack in J&K, two security personnel killed

WhatsApp OTP scam: What is it and how to stay safe?



Related Articles More

K’taka COVID-19 update: 1630 new cases, 1333 discharges, 19 deaths on Nov 24

PM has indicated COVID vaccine likely to be ready soon: Yediyurappa

K’taka COVID-19 update: 1870 new cases, 1949 discharges, 17 deaths on Nov 23

Thanksgiving could be make-or-break in US virus response

COVID-19 vaccine: India Aatmanirbhar for syringes, says industry

MUST WATCH

Centuries-old Tuluva ritual of ‘Bhoomipuje Gaddekori’ still performed at Palthadi Village in Puttur

A bike rider dies in a lorry crash : The scene of the accident was captured on CCTV

Moodbidri: Four people drowned in Shambhavi river

1348 new vented dams in K’taka’s coastal districts: J.C. Madhu Swamy

Karavali gets introduced to Japanese ‘kokedama’ art

Latest Additions

Pakistan fails to nab 19 most wanted LeT terrorists even 12 years after 26/11 attack

Speculation rife in Karnataka as CM convenes meeting of cabinet, MPs

‘Today is Punjab’s 26/11′: Sukhbir Badal on stopping farmers’ Delhi Chalo march

China, India in ‘candid, in-depth communication’ to disengage troops in eastern Ladakh: Chinese military

Farmers’ protest: Vigil stepped up in Delhi’s bordering areas, vehicles being checked

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.